Location History:
- Halifax, CA (2013)
- Toronto, CA (2022)
Company Filing History:
Years Active: 2013-2022
Title: Innovations and Contributions of Shengguo Sun
Introduction
Shengguo Sun is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antimicrobial compounds and treatments for amyloid diseases. With a total of 2 patents, his work reflects a commitment to advancing medical science.
Latest Patents
Shengguo Sun's latest patents include innovative compounds such as diphenyl substituted thiophene-2-amide derivatives and pharmaceutical compositions that are useful as antimicrobial agents. Additionally, he has developed methods for treating amyloid diseases using analogs of 1-(4-nitrophenyl) piperazine, which are directed towards inhibiting amyloid aggregation.
Career Highlights
Throughout his career, Shengguo Sun has worked with various companies, including Denovamed Inc. and Treventis Corporation. His experience in these organizations has allowed him to apply his research and innovations in practical settings, contributing to the development of new therapeutic solutions.
Collaborations
Some of his notable coworkers include Christopher J Barden and Fan Wu, who have collaborated with him on various projects. Their combined expertise has further enhanced the impact of their research in the pharmaceutical field.
Conclusion
Shengguo Sun's contributions to innovation in pharmaceuticals demonstrate his dedication to improving health outcomes through research and development. His patents and collaborations highlight the importance of teamwork in advancing scientific knowledge and creating effective treatments.